Sanofi's M&A misses frustrate some investors in drugmaker

PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker.

Sanofi's M&A misses frustrate some investors in drugmaker
Read More


Bagikan Berita Ini